Phase I study of 5-azacytidine and oxaliplatin in patients with advanced cancers relapsed or refractory to platinum compounds

被引：0

作者：

Tsimberidou, Apostolia M. ^{[1
]}

Culotta, Kirk ^{[1
]}

Wistuba, Ignacio ^{[1
]}

Fu, Siqing ^{[1
]}

Naing, Aung ^{[1
]}

Falchook, Gerald ^{[1
]}

Piha-Paul, Sarina ^{[1
]}

Zinner, Ralph ^{[1
]}

Rodriguez-Canales, Jaime ^{[1
]}

He, Guangan ^{[1
]}

Siddik, Zahid H. ^{[1
]}

Jelinek, Jaroslav ^{[2
]}

Chung, Woonbok ^{[2
]}

Ye, Yang ^{[1
]}

Said, Rabih ^{[3
]}

Hess, Kenneth ^{[1
]}

Stewart, David J. ^{[4
]}

Kurzrock, Razelle ^{[5
]}

Issa, Jean-Pierre ^{[2
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA

[3] UT Hlth Sci Ctr, Houston, TX USA

[4] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada

[5] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-CT201

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CT201

引用

页数：2

共 50 条

[1] Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Tsimberidou, Apostolia M.
Said, Rabih
Culotta, Kirk
Wistuba, Ignacio
Jelinek, Jaroslav
Fu, Siqing
Falchook, Gerald
Naing, Aung
Piha-Paul, Sarina
Zinner, Ralph
Siddik, Zahid H.
He, Guangan
Hess, Kenneth
Stewart, David J.
Kurzrock, Razelle
Issa, Jean-Pierre J.
CLINICAL EPIGENETICS, 2015, 7 : 1 - 11
[2] Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy
Apostolia M Tsimberidou
Rabih Said
Kirk Culotta
Ignacio Wistuba
Jaroslav Jelinek
Siqing Fu
Gerald Falchook
Aung Naing
Sarina Piha-Paul
Ralph Zinner
Zahid H Siddik
Guangan He
Kenneth Hess
David J Stewart
Razelle Kurzrock
Jean-Pierre J Issa
Clinical Epigenetics, 2015, 7
[3] Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers
Braiteh, Fadi
Soriano, Andres O.
Garcia-Manero, Guillermo
Hong, David
Johnson, Marcella M.
Silva, Leandro De Padua
Yang, Hui
Alexander, Stefanie
Wolff, Johannes
Kurzrock, Razelle
CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6296 - 6301
[4] Phase I Study of Inhaled 5-Azacytidine in Patients with Advanced NSCLC
Yilmaz, Emrullah
Meng, Haiying
Piperdi, Bilal
Shah, Chirag D.
Spivack, Simon D.
Gucalp, Rasim A.
Keller, Steven M.
Perez-Soler, Roman
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S555 - S555
[5] PHASE-I STUDY OF 5-AZACYTIDINE
VOGLER, WR
ARKUN, SN
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 59 - &
[6] Combination of 5-azacytidine (5-AZA) and valproic acid (VPA) in advanced solid cancers: A phase I study
Soriano, A. O.
Braiteh, F.
Garcia-Manero, G.
Camacho, L. H.
Hong, D.
Moulder, S.
Ng, C.
Kurzrock, R.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[7] A phase I study of 5-azacytidine () and erlotinib (E) for patients (pt) with advanced solid tumors
Verschraegen, Claire
Muller, Carolyn
Bauman, Julie
Rutledge, Teresa
Jones, Dennie
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[8] A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies
Julie Bauman
Claire Verschraegen
Steven Belinsky
Carolyn Muller
Teresa Rutledge
M. Fekrazad
Meera Ravindranathan
Sang-Joon Lee
Dennie Jones
Cancer Chemotherapy and Pharmacology, 2012, 69 : 547 - 554
[9] A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies
Bauman, Julie
Verschraegen, Claire
Belinsky, Steven
Muller, Carolyn
Rutledge, Teresa
Fekrazad, M.
Ravindranathan, Meera
Lee, Sang-Joon
Jones, Dennie
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 547 - 554
[10] Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia
Kritz, AD
Raptis, G
MenendezBotet, C
Maslak, P
Jakubowski, A
AMERICAN JOURNAL OF HEMATOLOGY, 1996, 51 (02) : 117 - 121

← 1 2 3 4 5 →